Evidence map›Paper›PMID 39661390›Full record

ArticleJAMA network open2024

Buprenorphine Injection Among Rural Persons Who Inject Drugs.

Kaitlin A Zinsli, Elenore P Bhatraju, Judith Feinberg, Thomas J Stopka, Peter D Friedmann, William Zule, Hannah L F Cooper, April M Young, P Todd Korthuis, Mai T Pho and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kaitlin A ZinsliDepartment of Epidemiology, University of Washington, Seattle.
Elenore P BhatrajuDepartment of Medicine, University of Washington School of Medicine, Seattle.
Judith FeinbergWest Virginia University School of Medicine, Morgantown.
Thomas J StopkaDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts.
Peter D FriedmannDepartment of Medicine, University of Massachusetts Medical School-Baystate, Springfield.
William ZuleSubstance Abuse Treatment Evaluations and Interventions Program, RTI International, Research Triangle Park, North Carolina.
Hannah L F CooperRollins School of Public Health, Emory University, Atlanta, Georgia.
April M YoungDepartment of Epidemiology and Environmental Health, University of Kentucky, Lexington.
P Todd KorthuisDepartment of Medicine, Oregon Health Sciences University, Portland.
Mai T PhoDepartment of Medicine, University of Chicago Medical Center, Chicago, Illinois.
Wiley D JenkinsDepartment of Public Health Sciences, Clemson University, Clemson, South Carolina.
William C MillerDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill.
Vivian F GoDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill.
David W SealDepartment of Social, Behavioral, and Population Sciences, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Ryan P WestergaardUniversity of Wisconsin School of Medicine and Public Health, Madison.
Rob J FredericksenDepartment of Medicine, University of Washington School of Medicine, Seattle.
Joseph A DelaneyDepartment of Epidemiology, University of Washington, Seattle.
Judith I TsuiDepartment of Medicine, University of Washington School of Medicine, Seattle.

Funding

Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)UH3DA044829 · NIDA · UNIVERSITY OF CHICAGO · PI JENKINS, WILEY, PHO, MAI TUYET · 2019 to 2022
$5.2M
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)UH3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2019 to 2022
$4.4M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost ExtensionUH3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2019 to 2022
$4.0M
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)U24DA048538 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., TSUI, JUDITH · 2019 to 2023
$3.7M
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak InvestigationU24DA044801 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2017 to 2022
$3.3M
Community-based, client-centered prevention homes to address the rural opioid epidemicUH3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2019 to 2022
$2.6M
Learning from the COVID-19 pandemic to improve emergency management planning for harm reduction services in rural OhioUH3DA044822 · NIDA · OHIO STATE UNIVERSITY · PI GO, VIVIAN F., MILLER, WILLIAM C · 2019 to 2022
$2.5M
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern AppalachiaUH3DA044823 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZULE, WILLIAM A · 2019 to 2021
$2.4M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UG3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D · 2017 to 2018
$1.6M
Community-based, client-centered prevention homes to address the rural opioid epidemicUG3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2017 to 2018
$1.4M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
Training in Equity and Structural Solutions in Addictions (TESSA)T32DA057920 · NIDA · UNIVERSITY OF WASHINGTON · PI GEETANJALI CHANDER, Judith Tsui · 2023 to 2026
$1.3M
NIDA NIH HHS K23 DA058751NIDA NIH HHS T32 DA057920NIDA NIH HHS U24 DA044801NIDA NIH HHS U24 DA048538NIDA NIH HHS UG3 DA044798NIDA NIH HHS UG3 DA044822NIDA NIH HHS UG3 DA044823NIDA NIH HHS UG3 DA044826NIDA NIH HHS UG3 DA044829NIDA NIH HHS UG3 DA044830NIDA NIH HHS UG3 DA044831NIDA NIH HHS UH3 DA044798NIDA NIH HHS UH3 DA044822NIDA NIH HHS UH3 DA044823NIDA NIH HHS UH3 DA044826NIDA NIH HHS UH3 DA044829NIDA NIH HHS UH3 DA044831
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39661390
PMCPMC11635541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.